Oncology Today with Dr Neil Love
Oncology Today with Dr Neil Love
✓

Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies

· وتظهر الملاحظات
00:47:06
Podcasts
RSS
Link

معلومات عن هذه الحلقة

Featuring an interview with Dr L Elizabeth Budde, including the following topics:

  • Considerations for selecting between bispecific antibodies (BsAbs); monotherapy versus combination therapy (0:00)
  • Management of BsAb-induced cytokine release syndrome and other toxicities (7:35)
  • Use of BsAbs in the front-line treatment of diffuse large B-cell lymphoma (DLBCL); key findings from the Phase II MorningSun study (17:30)
  • Case: A man in his mid 50s with relapsed/refractory (R/R) DLBCL receives mosunetuzumab and polatuzumab vedotin in the second-line setting (23:18)
  • Case: A woman in her early 70s with R/R DLBCL receives glofitamab monotherapy in the third-line setting (32:52)
  • Case: A man in his early 80s with R/R DLBCL experiences disease progression after lisocabtagene maraleucel therapy, which was bridged with epcoritamab and gemcitabine/oxaliplatin (37:35)

CME information and select publications

الطب
التعليم
الصحة واللياقة
الطب
العلوم
الإنجليزية
الولايات المتحدة
استخدمAPIلجلب هذه الحلقة فيJSON

في هذه الحلقة

تعديل هذه العلامات

وتظهر الملاحظات 🔗

00:00:00Considerations for selecting between bispecific antibodies (BsAbs); monotherapy versus combination therapy
00:07:35Management of BsAb-induced cytokine release syndrome and other toxicities
00:17:30Use of BsAbs in the front-line treatment of diffuse large B-cell lymphoma (DLBCL); key findings from the Phase II MorningSun study
00:23:18Case: A man in his mid 50s with relapsed/refractory (R/R) DLBCL receives mosunetuzumab and polatuzumab vedotin in the second-line setting
00:32:52Case: A woman in her early 70s with R/R DLBCL receives glofitamab monotherapy in the third-line setting
00:37:35Case: A man in his early 80s with R/R DLBCL experiences disease progression after lisocabtagene maraleucel therapy, which was bridged with epcoritamab and gemcitabine/oxaliplatin

النص 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

البحث في الحلقات الماضية

البحث في الحلقات السابقة من Oncology Today with Dr Neil Love.
تضمين شريط البحث هذا في موقع الويب الخاص بك

حلقات أخرى في هذا البودكاست

Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Featuring perspectives from Dr Stephen V Liu and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: Introduction (0:00) EGFR Mutations (2:23) HER2 Alterations (22:40) Available and Investigational Immunotherapies (32:14) Small Cell Lung Cancer (40:48) CME information…
00:50:33
المشاركة
حفظ
Prostate Cancer with PTEN Deficiency — An Interview with Dr Neeraj Agarwal

Prostate Cancer with PTEN Deficiency — An Interview with Dr Neeraj Agarwal

Featuring an interview with Dr Neeraj Agarwal, including the following topics: Impact of PTEN deficiency on PI3K/AKT/mTOR pathway; optimal approaches to testing (0:00) Approaches to monitoring for disease progression in patients who are PTEN deficient; prognostic significance and implications for …
00:52:24
المشاركة
حفظ
HER2-Positive Gynecologic Cancers — Microlearning Activity 3: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

HER2-Positive Gynecologic Cancers — Microlearning Activity 3: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

Featuring perspectives from Dr Joyce F Liu, Dr David M O'Malley and Dr Brian M Slomovitz, moderated by Dr O'Malley, including the following topics: Case: A woman in her mid 60s with Stage II uterine carcinosarcoma treated with surgery followed by paclitaxel/carboplatin, whole-pelvic radiation and …
00:13:57
المشاركة
حفظ
Chronic Lymphocytic Leukemia — Investigators Discuss Optimal Management

Chronic Lymphocytic Leukemia — Investigators Discuss Optimal Management

Featuring perspectives from Dr Catherine C Coombs and Dr Matthew S Davids, including the following topics: Introduction (0:00) Minimal Residual Disease Assays in Community-Based Practice (1:24) New Developments in Previously Untreated Chronic Lymphocytic Leukemia (CLL) — Dr Davids (8:12) Richter T…
00:58:15
المشاركة
حفظ
إخلاء المسؤولية: البودكاست والأعمال الفنية المضمنة في هذه الصفحة مأخوذة من Dr. Neil Love، وهي مملوكة لمالكها وليست تابعة لشركة Listen Notes, Inc أو معتمدة منها.
PROMOTED
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
PodcastAPI.com

التوصيات
استخدم واجهة API لتنفيذ هذه الحلقة